110225 ⎘
Reverse transcribing DNA viruses; Details; Hepadnaviridae; Orthohepadnavirus, e.g. hepatitis B virus New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Hepatitis B Virus Receptor OATP and Use Thereof
#2HBV VACCINES AND METHODS TREATING HBV
#3USE OF VIRUS-LIKE PARTICLES IN VACCINATION
#4METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B INFECTION
#5ADENOVIRAL VECTORS ENCODING HEPATITIS B VIRAL ANTIGENS FUSED TO HERPES VIRUS GLYCOPROTEIN D AND METHODS OF USING THE SAME
#6ENGINEERED MEGANUCLEASES SPECIFIC FOR RECOGNITION SEQUENCES IN THE HEPATITIS B VIRUS GENOME
#7METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B INFECTION
#8GLYCOSYL-MODIFIED FUSION PROTEIN, NUCLEIC ACID MOLECULE, EXPRESSION VECTOR, HOST CELL AND APPLICATIONS THEREOF
#9EPITOPE PEPTIDE AND ANTIBODY FOR TREATING HBV INFECTION AND RELATED DISEASES
#10T-Cell Modulatory Multimeric Polypeptide with Conjugation Sites and Methods of Use Thereof
#11ADENOVIRUSES AND METHODS FOR USING ADENOVIRUSES
#12HBV VACCINE INDUCING PRES-SPECIFIC NEUTRALIZING ANTIBODIES
#13HEPATITIS B IMMUNISATION REGIMEN AND COMPOSITIONS
#14MULTI-ANTIGEN THERAPEUTIC VACCINES TO TREAT OR PREVENT CHRONIC HEPATITIS B VIRUS INFECTION
#15AN IMMUNOGEN
#16ENGINEERED MEGANUCLEASES SPECIFIC FOR RECOGNITION SEQUENCES IN THE HEPATITIS B VIRUS GENOME
#17Methods and compositions for the treatment of hepatitis B infection
#18LIPOPEPTIDES FOR USE IN TREATING LIVER DISEASES AND CARDIOVASCULAR DISEASES
#19HBV VACCINE
#20VIRUS-LIKE PARTICLES AND METHODS OF PRODUCTION THEREOF
#21Adenoviral vectors encoding hepatitis b viral antigens fused to herpes virus glycoprotein d and methods of using the same
#22HBV VACCINES AND METHODS TREATING HBV
#23SCREENING MODEL AND METHOD FOR HBV CCCDNA-TARGETING DRUG
#24METHODS OF TREATMENT AND NOVEL CONSTRUCTS
#25HBV vaccines and methods treating HBV
#26Vaccines against hepatitis B virus
#27HEPADNAVIRUS CAPSID PROTEIN HETERODIMERS AND VIRUS-LIKE PARTICLES
#28ADENOVIRAL VECTORS ENCODING HEPATITIS B VIRAL ANTIGENS FUSED TO HERPES VIRUS GLYCOPROTEIN D AND METHODS OF USING THE SAME
#29ENGINEERED HEPATITIS B CORE POLYPEPTIDE
#30SUPERPARAMAGNETIC GOLD NANOPARTICLE CLUSTER-PROTEIN NANOPARTICLE FUSION BODY FOR MAGNETIC RESONANCE IMAGING AND MAGNETIC THERMOTHERAPY
#31Adenoviral vectors encoding hepatitis B viral antigens fused to herpes virus glycoprotein D and methods of using the same
#32COMBINATION THERAPY OF HBV AND HDV INFECTION
#33HEPATITIS B VIRUS VACCINE AND USES THEREOF
#34Methods and compositions for the treatment of hepatitis B infection
#35Method for efficiently inducing antibody, antibody and detection system for hepatitis virus
#36Hepatitis B virus (HBV) vaccines and uses thereof
#37Compositions and methods for treating viral infections
#38Chimeric hepatitis D virus antigen and hepatitis B virus pre S1 genes for use alone or in vaccines contaning hepatitis B virus genes
#39THERAPY OF ATHEROSCLEROSIS, PRIMARY BILIARY CIRRHOSIS AND NRLP3 INFLAMMASOME-ASSOCIATED DISEASE BY HTCP INHIBITORS
#40METHOD OF OBTAINING A POLYEPITOPIC PROTEIN AND POLYEPITOPIC DNA VECTOR
#41Engineered meganucleases specific for recognition sequences in the Hepatitis B virus genome
#42Hepatitis B immunization regimen and compositions
#43Treatment and prevention of house dust mite allergies
#44Tetravalent dengue vaccine
#45Methods of treatment and novel constructs
#46Modified antimicrobial peptide derived from an arginine-rich domain
#47HBV vaccines and methods treating HBV
#48Hepatitis B virus-derived polypeptide and anti-viral use thereof
#49Lipopeptides for Use in Treating Liver Diseases and Cardiovascular Diseases
#50T-cell modulatory multimeric polypeptide with conjugation sites and methods of use thereof
#51T-cell modulatory multimeric polypeptides comprising reduced-affinity immunomodulatory polypeptides
#52Engineered meganucleases specific for recognition sequences in the hepatitis B virus genome
#53Engineered hepatitis B core polypeptide
#54Non-immunogenic protein nanoparticles with cancer targeting activity using albumin-binding peptide
#55Virus-like particles including HBs-L antigen protein for causing immune response against HBV
#56Polypeptide carrier for presenting target polypeptide and uses thereof
#57IL-12 IMMUNOTHERAPY FOR CANCER
#58Vaccines against Hepatitis B virus
#59Fusion peptides with antigens linked to short fragments of invariant chain(CD74)
#60Engineered meganucleases specific for recognition sequences in the hepatitis B virus genome
#61Polypeptide construct comprising fragments of allergens
#62Polypeptide carrier for presenting target polypeptide and uses thereof
#63HBV antigen specific binding molecules and fragments thereof
#64Hepatitis B treatment vaccine on the basis of inactivated, whole recombinant Hansenula polymorpha cells expressing HBsAg
#65Tetravalent dengue vaccine
#66Hepatitis B virus (HBV) vaccines and uses thereof
#67Lipopeptides for use in treating liver diseases and cardiovascular diseases
#68Methods for treating or preventing HBV infection or HBV related diseases
#69Conserved HBV and HCV sequences useful for gene silencing
#70Chimeric hepatitis D virus antigen and hepatitis B virus pre S1 genes for use alone or in vaccines containing hepatitis B virus genes
#71Cyclic NTCP-targeting peptides and their uses as entry inhibitors
#72Tagged hepadnavirus E antigen and its use in screening antiviral substances
#73Compositions and methods for the treatment or prevention of hepatitis B virus infection
#74Therapy of atherosclerosis, primary biliary cirrhosis and NRLP3 inflammasome-associated disease by HTCP inhibitors
#75IMMUNOLOGICAL TEST KIT FOR EVALUATING VACCINE EFFICACY AND STORAGE METHOD THEREOF
#76Hepatitis B therapeutic vaccines
#77Recombinant self-assembling protein comprising target-oriented peptide and use thereof
#78Polypeptides and antibodies for treating HBV infection and related diseases
#79Tetravalent dengue vaccine
#80Tagged hepadnavirus e antigen and its use in screening antiviral substances
#81HBV polymerase mutants
#82SELF-ASSEMBLING NANOPARTICLE DRUG DELIVERY SYSTEM
#83Formulations of hepalatide
#84Method of obtaining a polyepitopic protein and polyepitopic DNA vector
#85IMMUNOGEN PLATFORM
#86SPECIFIC VIRUS-LIKE PARTICLE-CpG OLIGONUCLEOTIDE VACCINES AND USES THEREOF
#87Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#88Compositions and methods for the treatment or prevention of hepatitis B virus infection
#89Hepatitis B virus capsid assembly
#90EPITOPE AND ITS USE OF HEPATITIS B VIRUS SURFACE ANTIGEN
#91HEPATITIS B VIRUS VACCINES
#92Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#93Conserved HBV and HCV sequences useful for gene silencing
#94IL-12 immunotherapy for cancer
#95Hepatitis B virus pre-S1 derived synthetic polypeptides and uses thereof
#96ANTIBODY DISPLAY
#97Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
#98Vaccines against hepatitis B virus
#99Recombinant self-assembling protein comprising target-oriented peptide and use thereof
#100INDUCTION OF ANTIGEN-SPECIFIC TOLERANCE
#101INDUCTION OF IMMUNE RESPONSE
#102Detection and use of antiviral resistance mutations
#103Vaccine combinations
#104Lipopeptides for use in treating liver diseases and cardiovascular diseases
#105Peptide carrier fusion proteins as allergy vaccines
#106Stabilized hepatitis B core polypeptides
#107Development of HBV-and/or HDV-susceptible cells, cell lines and non-human animals
#108METHODS AND COMPOSITIONS FOR CONTROLLING ASSEMBLY OF VIRAL PROTEINS
#109Polypeptides and antibodies for treating HBV infection and related diseases
#110Compositions and methods for the treatment or prevention of hepatitis B virus infection
#111Membrane proximal region of HIV GP41 anchored to the lipid layer of a virus-like particle vaccine
#112Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
#113Hydrophobic modified peptides for liver specific diagnosis
#114Hepatitis B virus vaccines
#115Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
#116HBV polymerase mutants
#117Compositions and methods for the treatment or prevention of hepatitis B virus infection
#118Conserved HBV and HCV sequences useful for gene silencing
#119Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
#120Peptide carrier fusion proteins as allergy vaccines
#121Modified viral structural protein with antiviral activity
#122Epitope and its use of hepatitis B virus surface antigen
#123Yeast-based therapeutic for chronic hepatitis B infection
#124Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
#125Methods and compositions for controlling assembly of viral proteins
#126HBV drug resistance methods
#127HEPATITIS B VIRUS PRE-S1 DERIVED SYNTHETIC POLYPEPTIDES AND USES THEREOF
#128NANOHAIR STRUCTURE AND AN APPLICATION THEREFOR
#129HBV CORE ANTIGEN PARTICLES WITH MULTIPLE IMMUNOGENIC COMPONENTS ATTACHED VIA PEPTIDE LIGANDS
#130SELF-ASSEMBLING NANOPARTICLE DRUG DELIVERY SYSTEM
#131Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
#132Vaccine for Modulating Between T1 and T2 Immune Responses
#133Vaccine for modulating between T1 and T2 immune responses
#134MEGANUCLEASE VARIANTS CLEAVING THE GENOME OF A PATHOGENIC NON-INTEGRATING VIRUS AND USES THEREOF
#135Chimeric protein, method for manufacturing the same, nano-sensor in which the chimeric protein is fixed, and application thereof
#136HEPATITIS B VIRUS MUTATION STRAIN WITH RESISTANCE TO ADEFOVIR DIPIVOXIL AND THE USES THEREOF
#137Molecular Antigen Array
#138Manufacture of vaccines that contain both hepatitis B virus surface antigens and surfactant
#139POLYPEPTIDE CARRIER PROTEIN
#140Chimeric antigens for eliciting an immune response
#141Compositions and methods that enhance an immune response
#142Conserved HBV and HCV sequences useful for gene silencing
#143Immunogen platform
#144Molecular Antigen Array
#145SELF-ASSEMBLING NANOPARTICLE DRUG DELIVERY SYSTEM
#146CHIMERIC THERAPEUTICS, COMPOSITIONS, AND METHODS FOR USING SAME
#147CHIMERIC THERAPEUTICS, COMPOSITIONS, AND METHODS FOR USING SAME
#148CHIMERIC THERAPEUTICS, COMPOSITIONS, AND METHODS FOR USING SAME
#149Compositions and methods for identifying antigens which elicit an immune response
#150FUSION PROTEINS COMPRISING DP-178 AND OTHER VIRAL FUSION INHIBITOR PEPTIDES USEFUL FOR TREATING AIDS
#151COMPOSITION FOR THE PROPHYLAXIS AND TREATMENT OF HBV INFECTIONS AND HBV-MEDIATED DISEASES
#152Polynucleotides allowing the expression and secretion of recombinant pseudo-virus containing foreign epitopes, their production, and use
#153Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
#154HEPATITIS VIRUS CORE PROTEINS AS VACCINE PLATFORMS AND METHODS OF USE THEREOF
#155Viral variants with altered susceptibility to nucleoside analogs and uses thereof
#156Antigenic compositions and use of same in the targeted delivery of nucleic acids
#157HEPATITIS B VIRUS PRE-S1 DERIVED SYNTHETIC POLYPEPTIDES AND USES THEREOF
#158HBV vaccine and a process of preparing the same
#159SARS vaccine compositions and methods of making and using them
#160Immunogen platform
#161Fusion proteins and use thereof for preparing hepatitis C vaccines
#162Polynucleotides allowing the expression and secretion of recombinant pseudo-virus containing foreign epitopes, their production, and use
#163Membrane proximal region of HIV gp41 anchored to the lipid layer of a virus-like particle vaccine
#164MELAN-A-CARRIER CONJUGATES
#165Transmucosal administration of aggregated antigens
#166Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
#167Angiotensin peptide-carrier conjugates and uses thereof
#168PACKAGED VIRUS-LIKE PARTICLES FOR USE AS ADJUVANTS: METHOD OF PREPARATION AND USE
#169COMPOSITION FOR THERAPY AND/OR FOR PROPHYLAXIS OF HBV-INFECTIONS AND HBV-MEDIATED DISEASES
#170HOLLOW NANOPARTICLES AND USES THEREOF
#171Surface antigen protein mutant of hepatitis B virus surface antigen
#172NUCLEOTIDE VECTOR, COMPOSITION CONTAINING SUCH VECTOR, AND VACCINE FOR IMMUNIZATION AGAINST HEPATITIS
#173Hydrophobic modified pres-derived peptides of hepatitis B virus (HBV) and their use as vehicles for the specific delivery of compounds to the liver
#174Hydrophobic modified pres-derived peptides of hepatitis B virus (HBV) and their use as HBV and HDV entry inhibitors
#175In vivo delivery of double stranded RNA to a target cell
#176Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
#177Vaccines comprising an immunostimulatory peptide and an immunostimulatory oligodeoxynucleic acid molecule
#178Immunoprotective influenza antigen and its use in vaccination
#179Method for Efficient Purification of Bionanocapsule
#180METHODS AND COMPOSITIONS FOR INHIBITION OF MEMBRANE FUSION-ASSOCIATED EVENTS, INCLUDING HIV TRANSMISSION
#181IL-12 immunotherapy for cancer
#182HBV precore protein capable of forming particles
#183COMPOSITION AND METHOD FOR TREATING VIRAL INFECTION
#184Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same
#185Recombinant Rhinovirus Vectors
#186COMBINATION VACCINES WITH 1-HYDROXY-2-PHENOXYETHANE PRESERVATIVE
#187NUCLEIC ACID CONSTRUCTS
#188VIRAL VARIANTS AND METHODS FOR DETECTING SAME
#189COMPOSITIONS AND METHODS FOR TREATING INTRACELLULAR DISEASES
#190STABILIZED HBc CHIMER PARTICLES AS THERAPEUTIC VACCINE FOR CHRONIC HEPATITIS
#191Eukaryotic layered vector initiation systems
#192Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof
#193Hapten-carrier conjugates and uses thereof
#194RECOMBINANT PROTEINS AND VIRUS LIKE PARTICLES COMPRISING L AND S POLYPEPTIDES OF AVIAN HEPADNAVIRIDAE AND METHODS, NUCLEIC ACID CONSTRUCTS, VECTORS AND HOST CELLS FOR PRODUCING SAME
#195Packaging of Immunostimulatory Substances Into Virus-Like Particles: Method of Preparation and Use
#196Detection and use of antiviral resistance mutations
#197Inducing Cellular Immune Responses to Hepatitis B Virus Using Peptide and Nucleic Acid Compositions
#198Optimized multi-epitope constructs and uses thereof
#199Method and System for Optimizing Minigenes and Peptides Encoded Thereby
#200Surface protein (HBsAg) variant of the hepatitis B virus
#201Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
#202Split-core-particles for the presentation of foreign molecules, especially for vaccine applications, and method for their production
#203THERAPEUTIC, PROPHYLACTIC AND DIAGNOSTIC AGENTS FOR HEPATITIS B
#204Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and hepatitis B virus
#205Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
#206VIRUS LIKE PARTICLES
#207Polypeptide carrier protein
#208Self-assembling nanoparticle drug delivery system
#209VACCINE DELIVERY SYSTEM
#210IMMUNOGEN PLATFORM
#211Capsid proteins and uses therefore
#212Simian tropic, recombinant human immunodeficiency-1 viruses
#213Hepatitis B virus DNA polymerase and surface antigen variants and methods of using same
#214Viral variants detection and application
#215Manufacture of Vaccines That Contain Both Hepatitis B Virus Surface Antigen and Surfactant
#216Antigen Arrays for Treatment of Allergic Eosinophilic Diseases
#217Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
#218Purification of HBV antigens for use in vaccines
#219Vector for anti-HPV vaccine and transformed microorganism by the vector
#220Hepatitis B pre-S2 nucleic acid
#221Nucleotide vector, composition containing such vector, and vaccine for immunization against hepatitis
#222POLYNUCLEOTIDES ALLOWING THE EXPRESSION AND SECRETION OF RECOMBINANT PSEUDO-VIRUS CONTAINING FOREIGN EPITOPES, THEIR PRODUCTION, AND USE
#223Viral variants with altered susceptibility to nucleoside analogs and uses thereof
#224Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
#225Immunogen platform
#226Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
#227TSG101-GAG INTERACTION AND USE THEREOF
#228Advanced genetic vaccines
#229SARS Vaccine Compositions and Methods of Making and Using Them
#230HLA binding peptides and their uses
#231Bacteriophage-mediated immunisation against hepatitis
#232Highly-Sensitive Genomic Assays Employing Chimeric Bacteriophage Standards
#233Anti-malaria vaccine
#234Host Cells Containing Multiple Integrating Vectors
#235Molecular antigen arrary
#236Dmt-derivative compounds and related compositions and methods of use
#237Compositions for inducing an immune response against hepatitis B
#238Hiv Gp-41-Membrane Proximal Region Arrayed On Hepatitis B Surface Antigen Particles as Novel Antigens
#239Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereof
#240Frizzled proteins and detection and treatment of cancer
#241Method of detecting hepatitis B virus s antigen
#242Immunodeficiency recombinant poxvirus
#243Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
#244Viral variants
#245Recombinant HBsAg virus-like particles containing polyepitopes of interest, their production and use
#246Polynucleotides allowing the expression and secretion of recombinant HBsAg virus-like particles containing a foreign peptide, their production and use
#247HIV capsid assembly-associated compositions and methods
#248Nucleic acid constructs
#249Methods of inducing mucosal immunity
#250Hepadna virus core proteins as vaccine platforms and methods of use thereof
#251Compositions and methods for identifying antigens which elicit an immune response
#252Hepatitis virus core proteins as vaccine platforms and methods of use thereof
#253Recombinant plasmid and method for expressing hepatitis B viral antigens and virions in vivo
#254Hybrid or chimeric polynucleotides, proteins, and compositions comprising hepatitis B virus sequences
#255Hepatitis B virus surface antigen mutant and methods of detection thereof
#256Nucleic acid amplification controls
#257Nucleic acid amplification controls
#258Nucleic and Protein Sequences from the Hxhv Virus and Uses Thereof
#259HBV core antigen particles with multiple immunogenic components attached via peptide ligands
#260Pharmaceutical Compositions for Therapeutic Use
#261Therapeutic, Prophylactic and Diagnostic Agents for Hepatitis B
#262HBV variants detection and application
#263Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids
#264Antifusogenic proteins comprising human immunodeficiency virus type 1 (HIV-1) gp41 DP-178 polypeptide variants and a macromolecular carrier
#265Process for the preparation and purification of recombinant proteins
#266Sequence of reverse transcriptase gene and method of use
#267Antigen arrays for treatment of bone disease
#268Hepatitis B virus pre-S1 derived synthetic polypeptides and uses thereof
#269Antigen arrays for treatment of allergic eosinophilic diseases
#270Angiotensin peptide-carrier conjugates and uses thereof
#271Optimization of immunomodulatory properties of genetic vaccines
#272Optimization of immunomodulatory properties of genetic vaccines
#273Viral deconstruction through capsid assembly in vitro
#274Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
#275Substance carrier using hollow nanoparticle of hepatitis B virus protein and liposome, and method of introducing substance into cell
#276Optimized multi-epitope constructs and uses thereof
#277Molecular antigen array
#278Diagnostic method for brain damage-related disorders
#279Variants of hepatitis B virus resistant against some nucleoside analogues, but sensitive to others, and uses thereof
#280Nucleic acid vaccine compositions having a mammalian CD80/CD86 gene promoter driving antigen expression
#281Use of alum and a th1 immune response inducing adjuvant for enhancing immune responses
#282Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission
#283Influenza immunogen and vaccine
#284Method of making modified immunodeficiency virus particles
#285Specificity exchangers that redirect antibodies to a pathogen
#286Vaccine-induced hepatitis B viral strain and uses thereof
#287Stabilized immunogenic HBc chimer particles
#288Webbed immunogens comprising recombinant human immunodeficiency virus (HIV) envelope glycoproteins and the M9 scorpion toxin
#289METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF VIRAL AND BACTERIAL INFECTIONS
#290Polyepitope carrier protein
#291Self-assembling nanoparticle drug delivery system
#292Hollow nanoparticles of protein and drug using the same
#293Novel hepatitis B virus
#294Vaccines
#295Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use
#296Packaged virus-like particles
#297Immunoprotective influenza antigen and its use in vaccination
#298Immunogen for preparation of therapeutic vaccines or drugs for treatment of hepatitis B and the producing method and use thereof
#299Hepatitis-B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
#300Composition for the prophylaxis and treatment of HBV infections and HBV-mediated diseases